Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 829 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian MOST POPULAR Ethnic Diversity and Disparities in Access to Genetic Testing Impact Prostate... November 28, 2022 Women Experience More Side Effects from Pelvic Radiation than Realized April 8, 2020 177Lu-PSMA-617 Prolongs rPFS Relative to Androgen Receptor Pathway Inhibitor Change, with... September 23, 2024 2025 ESMO Society Award recipients announced August 5, 2025 Load more HOT NEWS A Combination of Talazoparib and Enzalutamide Prolongs OS in Unselected and... Women in Science: Celebrating with our Women of Influence initiative Pembrolizumab Does Not Prolong Overall Survival Compared to Chemotherapy in Platinum-Pretreated... Commemorating the Contributions of Cancer Research Greats
